Comera Life Sciences Holdings, Inc.
SEC CIK 1907685 · CMRA · last insider filing 2024-02-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wexler William A. | Director | filed 2022 - 2023 |
| Flowers Kirsten | Director | filed 2022 - 2023 |
| Sherblom James | Director | filed 2022 - 2023 |
| Banerjee Sirshendu Roopom | Director | filed 2022 - 2023 |
| Sullivan Edward Aloysius Jr. | Director | filed 2022 - 2023 |
| Clarke Dorothy J | Director | filed 2023 - 2023 |
| Hackman Jeffrey S. | Director · See Remarks. | filed 2022 - 2023 |
| Randle Stuart A | Director | filed 2022 - 2023 |
| Finck Barbara K | Director | filed 2022 - 2023 |
| Yee John D. | Director | filed 2022 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Campbell Michael Gerard | EVP & CFO | filed 2022 - 2023 |
| Muni Neal | See Remarks | filed 2022 - 2023 |
| Mccourt Janice | Chief Business Officer | filed 2022 - 2023 |
| Mahoney Robert Patrick | Chief Scientific Officer | filed 2022 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.